3861 results for «366»
3861 results
How to deal with thrombus during PCI for STEMI - Part 1
21 May 2019 – From EuroPCR 2019
Consult this session to discover various ways to manage thrombus during PCI for STEMI, thanks to a variety of compelling cases: heavily thrombotic and occluded ectatic 10mm vessel in ACS, anterior STEMI secondary to in situ thrombus formation due to congenital immune deficiency syndrome, and more!
Abstracts in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various abstracts in TAVI, such as: combination of malnutrition and muscle weakness deteriorates clinical outcomes after TAVR, 3D printed silicone casted TAVI training simulator, TAVR with the new balloon-expandable SAPIEN 3 Ultra vs. SAPIEN 3 valve system, and more!
Cases in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging TAVI cases, such as: subacute occlusion of right coronary artery after surgical aortic valve replacement, large post-myocardial infarction ventricular septum defect closure, NSTEMI after complex PCI and transfemoral TAVI procedure, and more!
Stroke Prevention Day - Essentials in LAA closure
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patient selection for LAA closure, the importance of TEE/CT imaging to identify LAA anatomy/morphology, and discover how to detect immediate/late complications and how to manage them, thanks to a selection of various challenging cases.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
PCR Tokyo Valves 2020: Selection of the best abstracts
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best abstracts submitted at PCR Tokyo Valves 2020: the efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy, inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve, and more!
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
TAVI basics Co-Medicals - in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.
My best and worst cases of vascular access
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn thanks to a selection of challenging transcatheter aortic valve implantation cases how to analyse the access sites required, how to manage difficult access and complications, and discover some new approaches.
Aortic Valve Thrombosis
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.
Shared decision making in low-risk patients with aortic stenosis
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
How to optimise PCI in a patient with multivessel disease? LIVE Case
19 Dec 2019 – From GulfPCR-GIM 2019
Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.
The objectives of this case are:
- Assess your patient as a whole package!
- Lesion preparation is key for...
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
